Steven Cohen’s ArriVent BioPharma AVBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$14.9M Sell
493,205
-73,591
-13% -$2.25M 0.02% 1091
2026
Q2
$19.7M Sell
566,796
-181,399
-24% -$5.35M 0.02% 903
2026
Q1
$17.3M Buy
748,195
+531,535
+245% +$12M 0.02% 885
2025
Q4
$4.36M Buy
+216,660
New +$4.51M ﹤0.01% 1939
2024
Q2
– Sell
-28,900
Closed -$516K – 2543
2024
Q1
$516K Buy
+28,900
New +$583K ﹤0.01% 1641

Other funds holding AVBP

Steven Cohen's AVBP Position: Q3 2026 in Review

Steven Cohen reduced its ArriVent BioPharma (AVBP) stake by 13% in Q3 2026, selling an estimated $2.25M and leaving 493,205 shares worth $14.9M. The position accounts for 0.02% of the portfolio, ranked #1091.

Steven Cohen first reported a position in AVBP in Q1 2024 and has held it in 5 quarters since. The position peaked at $19.7M in Q2 2026. 151 funds tracked by Wall St. Rank hold AVBP as of Q3 2026.

  • Steven Cohen held 493,205 shares of ArriVent BioPharma worth $14.9M as of Q3 2026.
  • Steven Cohen sold 73,591 ArriVent BioPharma shares in Q3 2026, an estimated $2.25M.
  • ArriVent BioPharma made up 0.02% of Steven Cohen's portfolio in Q3 2026, its #1091 holding.
  • Steven Cohen first reported a position in ArriVent BioPharma in Q1 2024 and has held it in 5 quarters since.
  • Steven Cohen's ArriVent BioPharma position peaked at $19.7M in Q2 2026.
  • 151 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.